Skip to main content
logo
Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.01
-0.27 (-4.30%)
At close: Jan 23, 2026, 4:00 PM EST
6.02
+0.01 (0.17%)
After-hours: Jan 23, 2026, 7:59 PM EST

Niagen Bioscience Market Cap

Niagen Bioscience has a market cap or net worth of $481.34 million as of January 23, 2026. Its market cap has increased by 16.69% in one year.

Market Cap
481.34M
Enterprise Value
420.25M
1-Year Change
16.69%
Ranking
#3112
Category
Small-Cap
Stock Price
$6.01

Market Cap Chart

Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $481.34M, a decrease of -47.09%. That is a compound annual growth rate of -3.55%.

History

DateMarket Cap% Change
Jan 23, 2026479.60M-5.52%
Dec 31, 2025507.60M25.27%
Dec 31, 2024405.20M277.28%
Dec 29, 2023107.40M-14.15%
Dec 30, 2022125.10M-51.02%
Dec 31, 2021255.40M-13.89%
Dec 31, 2020296.60M15.50%
Dec 31, 2019256.80M35.87%
Dec 31, 2018189.00M-33.29%
Dec 29, 2017283.30M125.74%
Dec 30, 2016125.50M-5.71%
Dec 31, 2015133.10M41.45%
Dec 31, 201494.10M-40.97%
Dec 31, 2013159.40M224.64%
Dec 31, 201249.10M19.76%
Dec 30, 201141.00M-49.88%
Dec 31, 201081.80M544.09%
Dec 31, 200912.70M-95.35%
Dec 31, 2008272.90M-70.00%
Jun 25, 2008909.70M-
View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Zevra Therapeutics504.99M
Monopar Therapeutics501.36M
Verastem492.42M
Aclaris Therapeutics487.55M
Bicycle Therapeutics482.80M
Contineum Therapeutics474.52M
Vanda Pharmaceuticals473.36M
Anavex Life Sciences469.97M
Market Cap Rankings